Karyopharm Therapeutics Enters $30M Securities Purchase Agreement With RA Capital For Selinexor Clinical Activities

Benzinga Newsdesk www.benzinga.com Positive 80.7%

Neg 0% Neu 0% Pos 80.7%

Comments

No comments yet. Be the first!